Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Rizk

Showing results (301-310 of 309) with videos related to

Pageof 31
Sort By:
You have reached the last page of results.This site can display upto 309 results.
Current Oncology Reports|November 15, 2018
Correction to: The Role of Oncolytic Viruses in the Treatment of MelanomaClaire-Audrey Y Bayan, Adriana T Lopez, Robyn D Gartrell, et al.
Journal of Affective Disorders|August 26, 2024
Relationships between serotonin 1A receptor DNA methylation, self-reported history of childhood abuse and gray matter volume in major depressionAriel R Goldenthal, Evan Lieberman, Mina M Rizk, et al.
Poultry Science|November 6, 2023
Impact of β-glucan dietary supplementation on productive, reproductive performance and physiological response of laying hens under heat stress conditionsWaheed Ezzat, Khalid M Mahrose, Ahmed M Rizk, et al.
Cancer Immunology, Immunotherapy : CII|January 9, 2022
Combination immunotherapy including OncoVEX<sup>mGMCSF</sup> creates a favorable tumor immune micro-environment in transgenic BRAF murine melanomaRobyn D Gartrell, Zoë Blake, Emanuelle M Rizk, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 17, 2019
Validation of Melanoma Immune Profile (MIP), a Prognostic Immune Gene Prediction Score for Stage II-III MelanomaRobyn D Gartrell, Douglas K Marks, Emanuelle M Rizk, et al.
Cancer Research|January 18, 2020
Linking Transcriptomic and Imaging Data Defines Features of a Favorable Tumor Immune Microenvironment and Identifies a Combination Biomarker for Primary MelanomaRobyn D Gartrell-Corrado, Andrew X Chen, Emanuelle M Rizk, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 23, 2019
Deep Learning Based on Standard H&E Images of Primary Melanoma Tumors Identifies Patients at Risk for Visceral Recurrence and DeathPrathamesh M Kulkarni, Eric J Robinson, Jaya Sarin Pradhan, et al.
Oncoimmunology|May 13, 2022
Neoadjuvant chemoradiation alters the immune microenvironment in pancreatic ductal adenocarcinomaRobyn D Gartrell, Thomas Enzler, Pan S Kim, et al.
Scientific Reports|February 3, 2021
Automated digital TIL analysis (ADTA) adds prognostic value to standard assessment of depth and ulceration in primary melanomaMichael R Moore, Isabel D Friesner, Emanuelle M Rizk, et al.
Pageof 31

Showing results (301-310 of 309) with videos related to

Sort By:
Pageof 31
You have reached the last page of results.This site can display upto 309 results.
Current Oncology Reports|November 15, 2018
Correction to: The Role of Oncolytic Viruses in the Treatment of MelanomaClaire-Audrey Y Bayan, Adriana T Lopez, Robyn D Gartrell, et al.
Journal of Affective Disorders|August 26, 2024
Relationships between serotonin 1A receptor DNA methylation, self-reported history of childhood abuse and gray matter volume in major depressionAriel R Goldenthal, Evan Lieberman, Mina M Rizk, et al.
Poultry Science|November 6, 2023
Impact of β-glucan dietary supplementation on productive, reproductive performance and physiological response of laying hens under heat stress conditionsWaheed Ezzat, Khalid M Mahrose, Ahmed M Rizk, et al.
Cancer Immunology, Immunotherapy : CII|January 9, 2022
Combination immunotherapy including OncoVEX<sup>mGMCSF</sup> creates a favorable tumor immune micro-environment in transgenic BRAF murine melanomaRobyn D Gartrell, Zoë Blake, Emanuelle M Rizk, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 17, 2019
Validation of Melanoma Immune Profile (MIP), a Prognostic Immune Gene Prediction Score for Stage II-III MelanomaRobyn D Gartrell, Douglas K Marks, Emanuelle M Rizk, et al.
Cancer Research|January 18, 2020
Linking Transcriptomic and Imaging Data Defines Features of a Favorable Tumor Immune Microenvironment and Identifies a Combination Biomarker for Primary MelanomaRobyn D Gartrell-Corrado, Andrew X Chen, Emanuelle M Rizk, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 23, 2019
Deep Learning Based on Standard H&E Images of Primary Melanoma Tumors Identifies Patients at Risk for Visceral Recurrence and DeathPrathamesh M Kulkarni, Eric J Robinson, Jaya Sarin Pradhan, et al.
Oncoimmunology|May 13, 2022
Neoadjuvant chemoradiation alters the immune microenvironment in pancreatic ductal adenocarcinomaRobyn D Gartrell, Thomas Enzler, Pan S Kim, et al.
Scientific Reports|February 3, 2021
Automated digital TIL analysis (ADTA) adds prognostic value to standard assessment of depth and ulceration in primary melanomaMichael R Moore, Isabel D Friesner, Emanuelle M Rizk, et al.
Pageof 31